IP disputes don't have to end your Series A.
Most founders treat IP threats as existential. We treat them as negotiating leverage — because that's what they are when you know how to read the room.
M&A sprints run on clarity, not billable hours.
We flat-fee every acquisition sprint under $50M. No clock-watching. No billing surprises. The engagement letter says what you pay; the term sheet says what you get.
Regulatory exposure is a data problem first.
Venture partners need diligence that surfaces risk in hours, not weeks. Our regulatory mapping process runs against 14 federal and state frameworks simultaneously.
The record speaks in numbers.
Selected transactions from 2021–2024. All outcomes verified. Client names withheld per engagement terms.
Dismissed patent troll claim in 38 days
SaaS platform, Series B. Competitor filed broad software patent suit 3 weeks before their fundraise close.
$187M acquisition of AI infrastructure co.
Buy-side representation for strategic acquirer. Full diligence, IP assignment, and rep & warranty insurance negotiated in 22 days.
Series A cap table restructuring
Converted $14M in SAFEs, cleaned up three conflicting option pool promises, and renegotiated pro-rata rights before the priced round.
FTC pre-merger clearance for fintech target
Mapped regulatory exposure across 9 state money-transmitter licenses and federal CFPB obligations for a PE fund acquiring a payments startup.
Patent portfolio sale — 47 patents
Represented seller in structured sale of machine-learning patent portfolio to strategic buyer. Negotiated carve-outs preserving core product freedom to operate.




